Raffaele Marchesi

Raffaele Marchesi

Auto-generated profile, based on publicly available information

Raffaele Marchesi

Affiliations Data Science for Health, Fondazione Bruno Kessler, Trento, Italy, Department of Mathematics, University of Pavia, Pavia, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
RMRaffaele Marchesi
Raffaele Marchesi
NMNicolo Micheletti
Nicolo Micheletti
NKNicholas I-Hsien Kuo
Nicholas I-Hsien Kuo
SBSebastiano Barbieri
Sebastiano Barbieri
Giuseppe JurmanGiuseppe Jurman
Giuseppe Jurman
VOVenet Osmani
Venet Osmani
Representation bias in health data can lead to unfair decisions and compromise the generalisability of research findings. As a consequence, underrepresented subpopulations, such as those from specific ethnic backgrounds or genders, do not benefit equally from clinical discoveries. Several approaches have been developed to mitigate representation bias, ranging from simple resampling methods, such as SMOTE, to recent approaches based on generative adversarial networks (GAN). However, generating high-dimensional time-series synthetic health data remains a significant challenge. In response, we devised a novel architecture (CA-GAN) that synthesises authentic, high-dimensional time series data. CA-GAN outperforms state-of-the-art methods in a qualitative and a quantitative evaluation while avoiding mode collapse, a serious GAN failure. We perform evaluation using 7535 patients with hypotension and sepsis from two diverse, real-world clinical datasets. We show that synthetic data generated by our CA-GAN improves model fairness in Black patients as well as female patients when evaluated separately for each subpopulation. Furthermore, CA-GAN generates authentic data of the minority class while faithfully maintaining the original distribution of data, resulting in improved performance in a downstream predictive task. Doctors and other healthcare professionals are increasingly using Artificial Intelligence (AI) to make better decisions about patients’ diagnosis, suggest optimal treatments, and estimate patients’ future health risks. These AI systems learn from existing health data which might not accurately reflect the health of everyone, particularly people from certain racial or ethnic groups, genders, or those with lower incomes. This can mean the AI doesn’t work as well for these groups and could even make existing health disparities worse. To address this, we have developed a purposely built AI software that can create synthetic patient data. Synthetic data created by our software mimics real patient data without actually copying them, protecting patients’ privacy. Using our synthetic data results in more representative dataset of all groups, and ensures that AI algorithms learn to be fairer for all patients.

27 September 2023 in medRxiv
Verified
Preprint
Open access
PDF file
RMRaffaele Marchesi
Raffaele Marchesi
NMNicolo Micheletti
Nicolo Micheletti
NKNicholas I-Hsien Kuo
Nicholas I-Hsien Kuo
SBSebastiano Barbieri
Sebastiano Barbieri
Giuseppe JurmanGiuseppe Jurman
Giuseppe Jurman
VOVenet Osmani
Venet Osmani
Representation bias in health data can lead to unfair decisions and compromise the generalisability of research findings. As a consequence, underrepresented subpopulations, such as those from specific ethnic backgrounds or genders, do not benefit equally from clinical discoveries. Several approaches have been developed to mitigate representation bias, ranging from simple resampling methods, such as SMOTE, to recent approaches based on generative adversarial networks (GAN). However, generating high-dimensional time-series synthetic health data remains a significant challenge. In response, we devised a novel architecture (CA-GAN) that synthesises authentic, high-dimensional time series data. CA-GAN outperforms state-of-the-art methods in a qualitative and a quantitative evaluation while avoiding mode collapse, a serious GAN failure. We perform evaluation using 7535 patients with hypotension and sepsis from two diverse, real-world clinical datasets. We show that synthetic data generated by our CA-GAN improves model fairness in Black patients as well as female patients when evaluated separately for each subpopulation. Furthermore, CA-GAN generates authentic data of the minority class while faithfully maintaining the original distribution of data, resulting in improved performance in a downstream predictive task. Author summary: Doctors and other healthcare professionals are increasingly using Artificial Intelligence (AI) to make better decisions about patients’ diagnosis, suggest optimal treatments, and estimate patients’ future health risks. These AI systems learn from existing health data which might not accurately reflect the health of everyone, particularly people from certain racial or ethnic groups, genders, or those with lower incomes. This can mean the AI doesn’t work as well for these groups and could even make existing health disparities worse. To address this, we have developed a purposely built AI software that can create synthetic patient data. Synthetic data created by our software mimics real patient data without actually copying them, protecting patients’ privacy. Using our synthetic data results in more representative dataset of all groups, and ensures that AI algorithms learn to be fairer for all patients.

16 April 2026 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
RMRaffaele Marchesi
Raffaele Marchesi
NLNicolò Lazzaro
Nicolò Lazzaro
WEWalter Endrizzi
Walter Endrizzi
GLGianluca Leonardi
Gianluca Leonardi
MPMatteo Pozzi
Matteo Pozzi
GJGiuseppe Jurman
Giuseppe Jurman
Integration of multimodal, multi-omics data is critical for advancing precision medicine, yet its application is frequently limited by incomplete datasets where one or more modalities are missing. To address this challenge, we developed a generative framework capable of synthesizing any missing modality from an arbitrary subset of available modalities. We introduce Coherent Denoising, a novel ensemble-based generative diffusion method that aggregates predictions from multiple specialized, single-condition models and enforces consensus during the sampling process. We compare this approach against a multi-condition, generative model that uses a flexible masking strategy to handle arbitrary subsets of inputs. The results show that our architectures successfully generate high-fidelity data that preserve the complex biological signals required for downstream tasks. We demonstrate that the generated synthetic data can be used to maintain the performance of predictive models on incomplete patient profiles and can leverage counterfactual analysis to guide the prioritization of diagnostic tests. We validated the framework’s efficacy on a large-scale multimodal, multi-omics cohort from The Cancer Genome Atlas (TCGA) of over 10,000 samples spanning across 20 tumor types, using data modalities such as copy-number alterations (CNA), transcriptomics (RNA-Seq), proteomics (RPPA), and histopathology (WSI). This work establishes a robust and flexible generative framework to address sparsity in multimodal datasets, providing a key step toward improving precision oncology.

13 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
RMRaffaele Marchesi
Raffaele Marchesi
NLNicolò Lazzaro
Nicolò Lazzaro
GLGianluca Leonardi
Gianluca Leonardi
FRFederica Rignanese
Federica Rignanese
SBStefano Bovo
Stefano Bovo
Giuseppe JurmanGiuseppe Jurman
Giuseppe Jurman
Background: Synthetic data generation is emerging as an approach to overcome the limitations of real-world data scarcity in omics studies, especially in precision medicine and oncology. Omics datasets, with their high dimensionality and relatively small sample sizes, often lead to overfitting, especially in deep learning models. Generative models offer a promising way to generate realistic synthetic data preserving the original data distribution. However, there is still no objective consensus on how to evaluate their performance. In this study, we set out to validate generative networks for transcriptomics data generation by using statistical distances as robust evaluation metrics. Results: We observe that statistical distances enable simultaneous evaluation of global and local data fidelity of generated synthetic data. Because these distances satisfy the properties of true metrics, they also enable formal hypothesis testing to assess whether generative models have in fact converged or are merely approaching the reference distribution. Crucially, optimizing for these distances was found to implicitly select models maximizing other widely used metrics of generative performance, providing evidence of their broad applicability. Overall, our findings indicate that the adoption of these metrics can play a key role in guiding the development of generative models across a wide range of domains.

26 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NLNicolo' Lazzaro
Nicolo' Lazzaro
RMRaffaele Marchesi
Raffaele Marchesi
GLGianluca Leonardi
Gianluca Leonardi
JTJacopo Tessadori
Jacopo Tessadori
MCMarco Chierici
Marco Chierici
Johan HenrikssonJohan Henriksson
Johan Henriksson
Comparing empirical distributions is central to generative model evaluation, hypothesis testing and data augmentation in high-dimensional biological data. Established methods such as energy distance summarize each point's relationship to the opposing distribution through a single expected distance, providing sensitivity to location shifts but not to local density or topological structure. We introduce Signature Distance (SD), a metric that compares empirical distributions through the mean absolute difference of their sorted pointwise distance profiles. SD is a structural generalization of energy distance and matches its $\mathcal{O}(n^2)$ computational complexity. On TCGA pan-cancer transcriptomic data, we show that (1) SD detects density changes that energy distance is insensitive to; (2) the per-point SD loss landscape reveals the geometric mechanisms behind known limitations of energy distance as a generative objective; (3) linearly interpolated biological samples that are not detected by energy distance are correctly penalized by SD; (4) SD provides a direct differentiable potential energy for model-free Langevin data expansion, with a bootstrap resampling protocol that stabilises the stopping epoch; and (5) SD is directly usable as a differentiable generative training loss.

27 August 2025 in bioRxiv
Verified
Preprint
Open access
RMRaffaele Marchesi
Raffaele Marchesi
NLNicolò Lazzaro
Nicolò Lazzaro
WEWalter Endrizzi
Walter Endrizzi
GLGianluca Leonardi
Gianluca Leonardi
MPMatteo Pozzi
Matteo Pozzi
GJGiuseppe Jurman
Giuseppe Jurman
Integration of multimodal, multi-omics data is critical for advancing precision medicine, yet its application is frequently limited by incomplete datasets where one or more modalities are missing. To address this challenge, we developed a generative framework capable of synthesizing any missing modality from an arbitrary subset of available modalities. We introduce Coherent Denoising, a novel ensemble-based generative diffusion method that aggregates predictions from multiple specialized, single-condition models and enforces consensus during the sampling process. We compare this approach against a multi-condition, generative model that uses a flexible masking strategy to handle arbitrary subsets of inputs. The results show that our architectures successfully generate high-fidelity data that preserve the complex biological signals required for downstream tasks. We demonstrate that the generated synthetic data can be used to maintain the performance of predictive models on incomplete patient profiles and can leverage counterfactual analysis to guide the prioritization of diagnostic tests. We validated the framework’s efficacy on a large-scale multimodal, multi-omics cohort from The Cancer Genome Atlas (TCGA) of over 10,000 samples spanning across 20 tumor types, using data modalities such as copy-number alterations (CNA), transcriptomics (RNA-Seq), proteomics (RPPA), and histopathology (WSI). This work establishes a robust and flexible generative framework to address sparsity in multimodal datasets, providing a key step toward improving precision oncology. Author Summary: To make precision medicine a reality, doctors need to understand a patient’s status from many angles, using different data types like genetic information (omics) and tissue slide images (histopathology). The problem is that most patient records are incomplete, with one or more of these data types missing, which can limit the effectiveness of powerful predictive tools. We have built a generative AI system designed to learn the complex biological patterns that connect all these different data types. By looking at the patient data that is available, our system can then generate a realistic, synthetic version of any missing piece. We developed a novel method called Coherent Denoising to do this, which is flexible and helps protect patient privacy. We validated this approach on a large dataset of over 10,000 cancer patient profiles. We show that our AI-generated data is high-fidelity and can successfully complete these sparse patient profiles, allowing AI models for crucial tasks like cancer staging and survival prediction to work at their best even with incomplete patient data. We also demonstrate how this tool can be used to evaluate the potential impact of new tests, helping to prioritize which expensive diagnostic tests would be most beneficial for a patient.